An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UVB-inflamed and normal skin
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UVB-inflamed and normal skin
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 75, Issue 2, Pages 404-414
Publisher
Wiley
Online
2012-07-10
DOI
10.1111/j.1365-2125.2012.04377.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Highly Sensitive LC--MS--MS Analysis of a Pharmaceutical Compound in Human Plasma Using Monolithic Phase-Based On-line Extraction
- (2013) R. N. Xu et al. JOURNAL OF CHROMATOGRAPHIC SCIENCE
- A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human Volunteers
- (2012) A. A. Othman et al. Clinical Pharmacology in Drug Development
- Guide to Receptors and Channels (GRAC), 5th edition
- (2011) SPH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacokinetics of the TRPV1 Antagonist ABT-102 in Healthy Human Volunteers: Population Analysis of Data From 3 Phase 1 Trials
- (2011) Ahmed A. Othman et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial
- (2011) Michael C. Rowbotham et al. PAIN
- TRPV1: On the Road to Pain Relief
- (2010) Andres Jara-Oseguera et al. Current Molecular Pharmacology
- Predicting therapeutic efficacy — Experimental pain in human subjects
- (2009) Boris A. Chizh et al. BRAIN RESEARCH REVIEWS
- TRPV1 controls acid- and heat-induced calcitonin gene-related peptide release and sensitization by bradykinin in the isolated mouse trachea
- (2009) Tatjana I. Kichko et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia
- (2009) Prisca Honore et al. PAIN
- Opioid Analgesics for Pain Control: Wisconsin Physicians' Knowledge, Beliefs, Attitudes, and Prescribing Practices
- (2009) Marla Z. Wolfert et al. PAIN MEDICINE
- Dilemmas in Chronic/Persistent Pain Management
- (2008) Warren A Katz et al. AMERICAN JOURNAL OF THERAPEUTICS
- Increased expression of TRPV1 channel in intrinsically aged and photoaged human skinin vivo
- (2008) Young Mee Lee et al. EXPERIMENTAL DERMATOLOGY
- Identification of (R)-1-(5-tert-Butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a Potent TRPV1 Antagonist for Pain Management
- (2008) Arthur Gomtsyan et al. JOURNAL OF MEDICINAL CHEMISTRY
- (R)-(5-tert-Butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) Blocks Polymodal Activation of Transient Receptor Potential Vanilloid 1 Receptors in Vitro and Heat-Evoked Firing of Spinal Dorsal Horn Neurons in Vivo
- (2008) C. S. Surowy et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now